Tris(benzyltriazolylmethyl)amine [[2-(2-hydroxy)ethoxy]ethyl] Quetiapine-d8 InChi: InChI=1S/C25H29N9O3/c1-35-15-16-36-19-6-4-18(5-7-19)32-11-8-31(9-12-32)10-13-33-23-20(17-27-33)24-28-22(21-3-2-14-37-21)30-34(24)25(26)29-23/h2-7

InChi: InChI=1S/C25H29N9O3/c1-35-15-16-36-19-6-4-18(5-7-19)32-11-8-31(9-12-32)10-13-33-23-20(17-27-33)24-28-22(21-3-2-14-37-21)30-34(24)25(26)29-23/h2-7

single dose) demonstrates brain penetrance with favorable pharmacokinetics

GW6471 at concentrations from 12

SN50 inhibits the activation of NF-κB and attenuates ventilator-induced lung injury

Prolonged treatment with KAT681 increases the hepatic expression of both low-density lipoprotein (LDL) receptor and scavenger receptor class B

Tris(benzyltriazolylmethyl)amine [[2-(2-hydroxy)ethoxy]ethyl] Quetiapine-d8 InChi: InChI=1S/C25H29N9O3/c1-35-15-16-36-19-6-4-18(5-7-19)32-11-8-31(9-12-32)10-13-33-23-20(17-27-33)24-28-22(21-3-2-14-37-21)30-34(24)25(26)29-23/h2-7Tris(benzyltriazolylmethyl)amine (TBTA) is a ligand that acts as a biochemical tool for the tagging of proteins and enzymes. Product information CAS Number: 510758 28 8 Molecular Weight: 530. 63 Formula: C30H30N10 Chemical Name: tris[(1 benzyl 1H 1,2,3 triazol 4 yl)methyl]amine Smiles: C(C1=CN(CC2C=CC=CC=2)N=N1)N(CC1=CN(CC2C=CC=CC=2)N=N1)CC1=CN(CC2C=CC=CC=2)N=N1 InChiKey: WKGZJBVXZWCZQC UHFFFAOYSA N InChi: InChI=1S C30H30N10 c1 4 10 25(11 5 1)16 38 22